Barbara Leyman
Chief Business Officer · SUTRO BIOPHARMA, INC.
Individual
- 2025
- Jul 8, 2025
- 1
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Barbara Leyman files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Connie Matsui - $40K in STRO purchases and sales in the last 12 months
- Gregory K. Chow - $16K in STRO purchases and sales in the last 12 months
- Hans-Peter Gerber - $14K in STRO purchases and sales in the last 12 months
- Jane Chung - $10K in STRO purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Barbara Leyman?
Barbara Leyman is a corporate insider, tracked as Chief Business Officer of SUTRO BIOPHARMA, INC. (STRO). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Barbara Leyman last file a Form 4?
The only primary Form 4 on record is dated 8 July 2025.
